To further confirm the role of CDC20 in prostate cancer, we found that the CDC20 protein abundance was positively correlated with the increased Gleason scores for prostate cancer based on a prostate cancer cohort of 102 cases (Fig. 1D, E, Additional file 1: Table S4). This evidence concerns the gene CDC20 and prostate carcinoma.